A. Riva

HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients

L. Mazzucchelli, L. Landi, F. Cappuzzo, 2013, British Journal of Cancer.

SensiScreen® KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations

S. Hamilton-Dutoit, M. Frattini, J. Lorenzen, 2017, PloS one.

Use of HER2 gene amplification to identify patients with metastatic colorectal cancer resistant to anti-EGFR monoclonal antibodies.

L. Landi, F. Cappuzzo, S. Tejpar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Deregulation of sialidases in human normal and tumor tissues.

E. Monti, A. Mozzi, F. Molinari, 2017, Cancer biomarkers : section A of Disease markers.

ALK Testing in Lung Adenocarcinoma: Technical Aspects to Improve FISH Evaluation in Daily Practice

L. Mazzucchelli, M. Frattini, W. Vermi, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression

E. Campo, A. Valera, E. Haralambieva, 2016, Modern Pathology.

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

Michael Børgesen, F. Molinari, M. Frattini, 2021, PloS one.

NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels.

L. Mazzucchelli, E. Monti, A. Mozzi, 2015, Glycobiology.

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assay

Michael Børgesen, A. L. Sørensen, M. Frattini, 2023, PloS one.